Loud Muscle Science Recalls Unapproved Capsule Product Marketed as Aphrodisia
Loud Muscle Science is recalling Launch Sequence Aphrodisia Capsules because they were marketed without FDA approval. The product was distributed nationwide in the USA and Canada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for an unapproved drug product. Per the rubric, this qualifies as a 'risk-of-harm product where injury has not yet been reported.' No illnesses or injuries have been documented, making the maximum score 3 per the explicit rubric rule.
Plain-English summary
Loud Muscle Science is recalling Launch Sequence Aphrodisia Capsules, sold in 4-count tins. The affected product has Lot number C07172101 with an expiration date of July 2024. The recall involves 1,500 4-count tins.
The product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), based on label claims that position it as an unapproved drug. This violates FDA regulations governing the approval and marketing of drug products.
The product was distributed nationwide in the United States and Canada. Consumers who purchased this product should stop using it.
Consumers who have used this product and experience any health concerns should contact their healthcare provider.
The recalled product
- Product
- Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.
- Manufacturer
- Loud Muscle Science
- Category
- Drug — Unapproved Drug
- Hazard
- unapproved-drug
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# C07172101
- Exp date: 07/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01